The Transformative Potential of Gene Therapies for Hemophilia
Hemophilia is an inherited blood disorder where victims suffer from uncontrolled bleeding post injuries. The major forms of the disease, Hemophilia A and B, are characterized by the genetic deficiency of factors VIII and IX, respectively. Of all the diverse therapies available, gene therapy holds incredible promise with its ability to cure the disease via a single-dose administration. Although safety and durability are the biggest hurdles for the field, “advances in gene therapy have been a terrific transformational change,” says Dr. John Pasi, an expert who has been closely involved in the design and development of clinical trials for new gene therapies.
It's free! Log in now to read
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115